CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae)☆☆
-
1 2018
-
-
Source: Antiviral Res. 149:75-77
[PDF-312.29 KB]
Details:
-
Alternative Title:Antiviral Res
-
Personal Author:
-
Description:Parechovirus A3 (Par-A3, formerly human parechovirus 3) is an emerging viral infection of the central nervous system in children. We used an automated, homogeneous, cell based assay to identify itraconazole and posaconazole as inhibitors of Par-A3, with antiviral activity below concentrations clinically attainable in pediatric patients. Currently, there is no approved antiviral treatment for Par-A3 infection, despite numerous reports of serious Par-A3 disease in neonates and infants.
-
Subjects:
-
Source:
-
Pubmed ID:29155163
-
Pubmed Central ID:PMC9169550
-
Document Type:
-
Funding:
-
Volume:149
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
